Thank you Maxime!!

Thank you @NINDS_NIH for putting your trust in this project.

Special thanks to Grégory Scherrer for his invaluable mentoring throughout the journey!

I'll be hitting the job market soon.

Stay tuned!

Big news! My K99 application has been awarded 🥳🎉

I'm excited to work together with @zenbrainest.bsky.social and @MarkZylka to explore how distinct peripheral neuron types shape pain representation in the brain.

Understanding how acute pain transitions to chronic pain after surgery is crucial, and we hope this review provides valuable insights into this complex process!

Mechanisms of chronic postsurgical pain Chronic pain after surgery, also known as chronic postsurgical pain (CPSP), is recognized as a significant public health issue with serious medical and economic consequences. Current research on CPSP ...

🌟 Excited to share our new review published in RAPM ! 🌟

Happy to have worked with Cyril Rivat and Philippe Richebé on this piece of work in which we explore the mechanisms underlying chronic post-surgical pain.

rapm.bmj.com/content/50/2...

FDA Approves Novel Non-Opioid Treatment for Moderate to Severe Acute Pain The FDA approved Journavx (suzetrigine) 50 mg oral tablets, a first-in-class non-opioid analgesic to treat moderate to severe acute pain in adults.

A big day for pain care, and for pain science. www.fda.gov/news-events/...

Structure-guided design of a peripherally restricted chemogenetic system Kang et al. present HCAD, a peripherally restricted DREADD based on HCA2, with a chemical actuator that avoids crossing the blood-brain barrier and selectively reduces pain in mice. This system will enable the study of peripheral physiology without affecting the central nervous system.

I am glad to share our recent work, now published in Cell! A @zenbrainest.bsky.social and Scherrer lab collaboration developing and validating a new peripherally restricted DREADD system! Great team work with Hye Jin Kang, Brian Krumm, @adrtas.bsky.social, and others
www.cell.com/cell/abstrac...